FOLDYNA, Daniel, Jan KAMELANDER, Marta KREJČÍ and Roman HÁJEK. Žádoucí a nežádoucí účinky thalidomidu u pacientů s mnohočetným myelomem (Desirable and undesirable effects of thalidomide in patients with multiple myeloma). Vnitřní lékařství. Praha: Česk lékařská společnost J. Ev. Purkyně, 2003, vol. 49, No 11, p. 859-868. ISSN 0042-773X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Žádoucí a nežádoucí účinky thalidomidu u pacientů s mnohočetným myelomem
Name (in English) Desirable and undesirable effects of thalidomide in patients with multiple myeloma
Authors FOLDYNA, Daniel (203 Czech Republic), Jan KAMELANDER (203 Czech Republic), Marta KREJČÍ (203 Czech Republic) and Roman HÁJEK (203 Czech Republic, guarantor).
Edition Vnitřní lékařství, Praha, Česk lékařská společnost J. Ev. Purkyně, 2003, 0042-773X.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords (in Czech) mnohočetný myelom; thalidomid
Keywords in English multiple myeloma;thalidomide
Tags multiple myeloma, Thalidomide
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 23/6/2009 16:28.
Abstract
V článku je popisován antimyelomový účinek thalidomidu a jeho nežádoucí účinky.
Abstract (in English)
Thalidomide, an antiemetic administered in 60th of the 20th century to pregnant women, has become notorious for a range of adverse effects which led to its taking off market. In recent years, its antimyeloma effect was discovered. The aim of the work was to evaluate the incidence of adverse reactions to thalidomide.
PrintDisplayed: 1/6/2024 13:11